(Q50720110)

18 March 2018

title

Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy. (English)

1 reference

18 March 2018

1 reference

1 reference

Shinya Yamamoto

1

1 reference

18 March 2018

Kuniya Tanaka

2

1 reference

18 March 2018

Kazuhisa Takeda

3

1 reference

18 March 2018

Hirotoshi Akiyama

4

1 reference

18 March 2018

Yasushi Ichikawa

5

1 reference

18 March 2018

Yoji Nagashima

6

1 reference

18 March 2018

Itaru Endo

7

1 reference

18 March 2018

publication date

20 February 2014

1 reference

18 March 2018

Annals of Surgical Oncology

published in

1 reference

18 March 2018

volume

21

1 reference

18 March 2018

issue

6

1 reference

18 March 2018

page(s)

1853-1861

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1245/s10434-014-3549-1

exact match

0 references

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Messenger RNA expression of COX-2 and angiogenic factors in primary colorectal cancer and corresponding liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

CD133 is essential for glioblastoma stem cell maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Dynamics of cancer cell subpopulations in primary and metastatic colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Human ATP-binding cassette (ABC) transporter family

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3549-1

10.1245/S10434-014-3549-1

21 January 2018

Identifiers

DOI

1 reference

18 March 2018

Dimensions Publication ID

0 references

1 reference

18 March 2018